INTERCEPT® Fibrinogen Complex in Cardiac Surgery: Experience at Stanford
Runtime: 15 min
Trauma, CV, and high-risk OB centers across the U.S. are implementing Pathogen Reduced Cryoprecipitated Fibrinogen Complex (INTERCEPT Fibrinogen Complex or IFC), to ensure fibrinogen and other key clotting factors are ready to transfuse in the first minutes of hemorrhage treatment. In this symposium, Dr. Worasak Keeyapaj will discuss the importance of timely fibrinogen supplementation during cardiac surgery, and how IFC’s 5-day post-thaw shelf life allows Stanford to achieve their treatment goals while decreasing product waste and improving blood availability for patients in need.
Worasak Keeyapaj, MD
Clinical Associate Professor
Division of Cardiac Anesthesia, Department of Anesthesiology Stanford University School of Medicine
Dr. Worasak Keeyapaj is a Clinical Associate Professor in the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University. Dr. Keeyapaj received his medical degree and anesthesia residency training at Chulalongkorn University in Bangkok, Thailand. He then further completed both anesthesia residency training and his adult cardiothoracic anesthesiology fellowship at the Cleveland Clinic Foundation.
His clinical interests focus on cardiothoracic anesthesiology, trans-esophageal echocardiography and peri-operative patient blood management (PBM). He also practices at the pre-operative anemia clinic at Stanford with a focus in peri-operative management of Jehovah’s Witness patients undergoing cardiac surgery. He helped establish the Center for Bloodless Cardiac Surgery (CBS) at Stanford Cardiovascular Hospital (CVH). He has also led successful peri-operative blood conservation initiatives in cardiac surgery. He is actively participating in quality improvement projects related to patient blood management for the operating room.
Watch the Replay
Runtime: 15 min